Aspira Women's Health Inc AWH:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 11:53 AM EDT
3.38quote price arrow down-0.05 (-1.46%)
Volume
7,697
52 week range
2.31 - 6.75
Loading...
  • Open3.67
  • Day High3.67
  • Day Low3.31
  • Prev Close3.43
  • 52 Week High6.75
  • 52 Week High Date09/01/23
  • 52 Week Low2.31
  • 52 Week Low Date07/27/23

Key Stats

  • Market Cap34.938M
  • Shares Out10.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-17.16

KEY STATS

  • Open3.67
  • Day High3.67
  • Day Low3.31
  • Prev Close3.43
  • 52 Week High6.75
  • 52 Week High Date09/01/23
  • 52 Week Low2.31
  • 52 Week Low Date07/27/23
  • Market Cap34.938M
  • Shares Out10.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.62
  • YTD % Change-17.16

RATIOS/PROFITABILITY

  • EPS (TTM)-9.78
  • P/E (TTM)-0.35
  • Fwd P/E (NTM)-2.55
  • EBITDA (TTM)-20.048M
  • ROE (TTM)-345.89%
  • Revenue (TTM)9.177M
  • Gross Margin (TTM)57.57%
  • Net Margin (TTM)-198.23%
  • Debt To Equity (MRQ)-253.72%

EVENTS

  • Earnings Date05/09/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Aspira Women's Health Inc

 

Profile

MORE
Aspira Women's Health Inc. is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. Its products include Ova1, Overa, Ova1Plus and OvaWatch. Ova1 is a blood test intended as an aid to further assess the likelihood of malignancy in women with an ovarian adnexal mass for which surgery is planned when the physician’s independent clinical and radiological evaluation does not indicate malignancy. Overa is a biomarker reflex intended to...
Jannie Herchuk
Independent Chairman of the Board
Nicole Sandford CPA
Chief Executive Officer, Director
Torsten Hombeck Ph.D.
Chief Financial Officer
Minh Merchant
General Counsel, Corporate Secretary
Address
Suite 100
12117 Bee Caves Road Building Three
Austin, TX
78738
United States

Top Peers

SYMBOLLASTCHG%CHG
BIOR
Biora Therapeutics Inc
1.10-0.07-5.97%
DMTK
DermTech Inc
0.712+0.003+0.4231%
ACON
Aclarion Inc
0.337+0.0115+3.533%
XGN
Exagen Inc
1.62+0.06+3.62%
CNTG
Centogene NV
0.6963+0.0063+0.913%